Literature DB >> 1937077

Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.

C Engler1, B Krogsaa, H Lund-Andersen.   

Abstract

Blood-retina barrier (BRB) permeability and its relation to the progression of diabetic retinopathy was studied over an 8-year period in 50 insulin-dependent diabetic patients. Initially, the patients underwent an ophthalmological examination, including measurement of best corrected visual acuity, fundus photography and vitreous fluorometry for determination of BRB permeability. After 8 years the patients were reexamined and their retinal status and clinical course were evaluated. We found a positive correlation between a high initial permeability value and an unfavorable clinical course using the parameter photocoagulation. A decrease in follow-up visual acuity was also associated with high initial permeability; however, this correlation was not statistically significant. A significant difference in mean blood pressure was found between values measured in laser-treated patients vs a group that did not undergo such therapy. Thus, in patients showing the same initial retinal morphology, high permeability seems to indicate an unfavorable disease course. The extent to which BRB permeability can be a valuable supplement to fluorescein angiography and three-mirror examination in the clinical decision process needs to be further evaluated.

Entities:  

Mesh:

Year:  1991        PMID: 1937077     DOI: 10.1007/bf00166307

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.

Authors:  M Larsen; E Hommel; H H Parving; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans.

Authors:  P Dalgaard; V A Barker; H Lund-Andersen
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-07       Impact factor: 4.799

Review 3.  The blood-ocular barriers.

Authors:  J Cunha-Vaz
Journal:  Surv Ophthalmol       Date:  1979 Mar-Apr       Impact factor: 6.048

4.  Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer.

Authors:  R C Zeimer; N P Blair; J G Cunha-Vaz
Journal:  Arch Ophthalmol       Date:  1983-11

5.  Theory and methodology of vitreous fluorophotometry.

Authors:  D M Maurice
Journal:  Jpn J Ophthalmol       Date:  1985       Impact factor: 2.447

6.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

7.  Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.

Authors:  S R Waltman
Journal:  Trans Am Ophthalmol Soc       Date:  1984

8.  Quantitative vitreous fluorophotometry applying a mathematical model of the eye.

Authors:  H Lund-Andersen; B Krogsaa; M la Cour; J Larsen
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin dependent diabetic patients.

Authors:  B Krogsaa; H Lund-Andersen; J Mehlsen; L Sestoft
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-12

10.  Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.

Authors:  H H Parving; M Larsen; E Hommel; H Lund-Andersen
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

View more
  8 in total

1.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

2.  Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.

Authors:  A Castillo; J M Benitez del Castillo; D Diaz; O Sayagues; J L Ruibal; J Garcia-Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

3.  Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.

Authors:  B Sander; M Larsen; C Engler; C Strøm; B Moldow; N Larsen; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

4.  Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

Authors:  Azza B El-Remessy; Mohamed Al-Shabrawey; Yousuf Khalifa; Nai-Tse Tsai; Ruth B Caldwell; Gregory I Liou
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis.

Authors:  Phillip S Coburn; Brandt J Wiskur; Elizabeth Christy; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

6.  Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study.

Authors:  J Cunha-Vaz; E Leite; J C Sousa; J R de Abreu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

7.  Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.

Authors:  Azza B El-Remessy; M Ali Behzadian; Gamal Abou-Mohamed; Telina Franklin; Robert W Caldwell; Ruth B Caldwell
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

8.  Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

Authors:  Paul Canning; Josephine V Glenn; Daniel K Hsu; Fu-Tong Liu; Tom A Gardiner; Alan W Stitt
Journal:  Exp Diabetes Res       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.